EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zygosity‐Dependent Phenotypic Spectrum of RELN ‐Related Disorders: 10 New Patients and Genotype–Phenotype Correlations Across 48 Kindreds

Sajjad Biglari iD, Halimeh Rezaei, Elnaz Asadollahzadeh iD, Mohammad Salimi Asl, Hamid Galehdari iD, Masoud Garshasbi iD, Emran Esmaeilzadeh, Raziyeh Khalesi, Payman Jamali iD, Farshid Parvini iD, Gholamreza Shariati, Niloofar Chamanrou iD und 18 weitere

Human Mutation · 2026

DOI: 10.1155/humu/9993570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Sajjad Biglari und 29 weiteren Autor:innen. Beteiligte Einrichtung: Farin Genetics Laboratory, Tehran, Iran. Hauptthemen laut MEDLINE: Genetic Association Studies, Nervous System Malformations, Nerve Tissue Proteins. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in RELN lead to a range of neurodevelopmental phenotypes, from autosomal recessive lissencephaly with cerebellar hypoplasia (LCH) (LIS2) to autosomal dominant focal epilepsies. We carried out exome sequencing (ES) on 10 affected individuals from eight unrelated Iranian families with consanguinity. Nine distinct variants were identified: Four are novel; four had been deposited in ClinVar without a reported affected individual; and the ninth, c.2015C>T, p.(Pro672Leu), had been reported only in heterozygous carriers with dominant epilepsy. In this study, we report the variant for the first time in the homozygous state, in a patient with the full recessive phenotype. The patients were pooled in a systematic review following PRISMA, updated to July 2026, with 28 papers, and all variants were reannotated against NM_005045.4, under a single ACMG/AMP framework. The primary cohort comprised 80 individuals from 48 kindreds (70 previously reported, 10 new) with 48 distinctive variants, of which 41 (85%) were pathogenic or likely pathogenic and five were variants of uncertain significance; two balanced rearrangements were not in either the sequence‐variant or copy‐number frameworks; and 16 individuals from nine kindreds with monoallelic candidate or susceptibility variants were analyzed separately. The age of onset was not continuous with no reports of onsets between 2.4 and 8 years. Zygosity did not account for this separation because monoallelic individuals occurred in both onset groups; in contrast, malformations of cortical development were documented in all 32 early‐onset individuals and in none of the 23 later onset individuals with evaluable neuroimaging. ES was the diagnostic method in 65% of individuals. Thus, zygosity contributes to the phenotypic severity in a broad spectrum of RELNopathies and supports carrier testing and reproductive counseling in consanguineous families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Association StudiesNervous System MalformationsNerve Tissue ProteinsHumansReelin ProteinFemalePhenotypeMalePedigreeExome SequencingChild, PreschoolChildMutationHomozygoteConsanguinityIranEpilepsyInfantAdultAdolescent

Stichwörter der Autor:innen

ACMG/AMP variant classificationRELNReelinautosomal dominant lateral temporal epilepsyexome sequencinggenotype–phenotype correlationlissencephaly with cerebellar hypoplasia

Substanzen

Reelin ProteinRELN protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Farin Genetics Laboratory, Tehran, Iran.
  • Department of Genetics, Faculty of Biological Sciences and Technology, Shahid Ashrafi Esfahani University, Isfahan, Iran, ashrafi.ac.ir.
  • Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran, tums.ac.ir.
  • Medical Genetics Department, Genetic Diagnosis Center, Colife Integrated Medical Laboratories, Tehran, Iran.
  • Medical Genetics Department, VestaLab Genetic Diagnosis Center, Tehran, Iran.
  • Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran, scu.ac.ir.

ORCID-Profile: Sajjad Biglari, Elnaz Asadollahzadeh, Hamid Galehdari, Masoud Garshasbi, Payman Jamali, Farshid Parvini, Niloofar Chamanrou, Hamid Reza Khorram Khorshid, Samira Nafar, Saeed Abtahi, Hassan Vahidnezhad, Mehran Beiraghi Toosi, Morteza Heidari, Hanieh Mirzadeh, Majid Mojarrad

Zitieren

APA

Biglari, S., Rezaei, H., Asadollahzadeh, E., Asl, M. S., Galehdari, H., Garshasbi, M., Esmaeilzadeh, E., Khalesi, R., Jamali, P., Parvini, F., Shariati, G., Chamanrou, N., Saligheh, R., Moghaddam, A. S., Khorshid, H. R. K., Shohani, S., Nafar, S., Eslahi, A., Lotfi, M., …, & Karimiani, E. G. (2026). Zygosity‐Dependent Phenotypic Spectrum of RELN ‐Related Disorders: 10 New Patients and Genotype–Phenotype Correlations Across 48 Kindreds. Human Mutation. https://doi.org/10.1155/humu/9993570

Vancouver

Biglari S, Rezaei H, Asadollahzadeh E, Asl MS, Galehdari H, Garshasbi M, et al. Zygosity‐Dependent Phenotypic Spectrum of RELN ‐Related Disorders: 10 New Patients and Genotype–Phenotype Correlations Across 48 Kindreds. Human Mutation. 2026. doi:10.1155/humu/9993570

BibTeX
@article{Biglari2026,
  author = {Biglari, Sajjad and Rezaei, Halimeh and Asadollahzadeh, Elnaz and Asl, Mohammad Salimi and Galehdari, Hamid and Garshasbi, Masoud and Esmaeilzadeh, Emran and Khalesi, Raziyeh and Jamali, Payman and Parvini, Farshid and Shariati, Gholamreza and Chamanrou, Niloofar and Saligheh, Reza and Moghaddam, Atefeh Sohanforooshan and Khorshid, Hamid Reza Khorram and Shohani, Sepideh and Nafar, Samira and Eslahi, Atieh and Lotfi, Mojtaba and Bakhshoodeh, Behnoosh and Hajizadeh, Fatemeh and Abtahi, Saeed and Jomehei, Reza Gharaei and Vahidnezhad, Hassan and Toosi, Mehran Beiraghi and Heidari, Morteza and Mirzadeh, Hanieh and Mojarrad, Majid and Sarband, Mina Mohammadi and Karimiani, Ehsan Ghayoor},
  title = {Zygosity‐Dependent Phenotypic Spectrum of RELN ‐Related Disorders: 10 New Patients and Genotype–Phenotype Correlations Across 48 Kindreds},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/9993570}
}
Kostenlos starten →